Expert RA rating agency has confirmed Binnopharm Group’s credit rating at the ruA level with a stable outlook
Expert RA, the largest credit rating agency, has confirmed Binnopharm Group’s creditworthiness rating at the ruA level with a stable outlook.
Binnopharm Group, LLC is one of the leading pharmaceutical companies in Russia with manufacturing facilities in various regions across Russia. According to AlphaRM analytical agency, by the end of 2022, the company was among the Top 7 pharmaceutical corporations in the retail market and ranked 2nd among domestic drug product manufacturers.
The Group’s stock has been trading in the Russian corporate bond market since 2021, and the company enjoys a credit rating of ruA (assigned by the Expert RA) with a stable outlook. Binnopharm Group’s bonds won the Best Initial Bond Placement for a Pharmaceutical Company nomination in CBonds Awards and were also highly rated by experts of RBC Investments and Otkritie Research.
